{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:18:39Z","timestamp":1793222319969,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09742-0","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T11:31:17Z","timestamp":1752147077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Comprehensive multi-omics and machine learning framework for glioma subtyping and precision therapeutics"],"prefix":"10.1038","volume":"15","author":[{"given":"Yi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaiyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"3","key":"9742_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2159-8290.CD-20-1474","volume":"11","author":"JG Nicholson","year":"2021","unstructured":"Nicholson, J. G. & Fine, H. A. Diffuse glioma heterogeneity and its therapeutic implications. Cancer Discov. 11(3), 575\u2013590. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1474 (2021).","journal-title":"Cancer Discov."},{"issue":"8","key":"9742_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro-Oncol. 23(8), 1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106 (2021).","journal-title":"Neuro-Oncol."},{"issue":"10","key":"9742_CR3","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi, M. E. et al. mgmt gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352(10), 997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331 (2005).","journal-title":"N. Engl. J. Med."},{"key":"9742_CR4","doi-asserted-by":"publisher","first-page":"1476436","DOI":"10.3389\/fimmu.2024.1476436","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu, J., Peng, J., Jiang, J. & Liu, Y. Clinical immunotherapy in glioma: Current concepts, challenges, and future perspectives. Front. Immunol. 15, 1476436. https:\/\/doi.org\/10.3389\/fimmu.2024.1476436 (2024).","journal-title":"Front. Immunol."},{"issue":"1","key":"9742_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","volume":"17","author":"H Lin","year":"2024","unstructured":"Lin, H. et al. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J. Hematol. Oncol. J. Hematol. Oncol. 17(1), 31. https:\/\/doi.org\/10.1186\/s13045-024-01544-7 (2024).","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"issue":"12","key":"9742_CR6","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.3390\/cancers15123158","volume":"15","author":"A Barzegar Behrooz","year":"2023","unstructured":"Barzegar Behrooz, A. et al. Integrating multi-omics analysis for enhanced diagnosis and treatment of glioblastoma: A comprehensive data-driven approach. Cancers 15(12), 3158. https:\/\/doi.org\/10.3390\/cancers15123158 (2023).","journal-title":"Cancers"},{"issue":"1","key":"9742_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin, Y., Seldin, M. & Lusis, A. Multi-omics approaches to disease. Genome Biol. 18(1), 83. https:\/\/doi.org\/10.1186\/s13059-017-1215-1 (2017).","journal-title":"Genome Biol."},{"issue":"1","key":"9742_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12885-021-07888-4","volume":"21","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y., Gao, Y., Xu, X., Zhou, J. & Wang, H. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma. BMC Cancer 21(1), 257. https:\/\/doi.org\/10.1186\/s12885-021-07888-4 (2021).","journal-title":"BMC Cancer"},{"key":"9742_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbw068","author":"S Min","year":"2016","unstructured":"Min, S., Lee, B. & Yoon, S. Deep learning in bioinformatics. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbw068 (2016).","journal-title":"Brief. Bioinform."},{"issue":"10","key":"9742_CR10","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein, J. N. et al. The cancer genome atlas pan-cancer analysis project. Nat. Genet. 45(10), 1113\u20131120. https:\/\/doi.org\/10.1038\/ng.2764 (2013).","journal-title":"Nat. Genet."},{"issue":"1","key":"9742_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from chinese glioma patients. Genom Proteom Bioinf 19(1), 1\u201312. https:\/\/doi.org\/10.1016\/j.gpb.2020.10.005 (2021).","journal-title":"Genom Proteom Bioinf"},{"issue":"6","key":"9742_CR12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28(6), 882\u2013883. https:\/\/doi.org\/10.1093\/bioinformatics\/bts034 (2012).","journal-title":"Bioinformatics"},{"issue":"1","key":"9742_CR13","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.1038\/s41598-017-11110-6","volume":"7","author":"G Nyamundanda","year":"2017","unstructured":"Nyamundanda, G., Poudel, P., Patil, Y. & Sadanandam, A. A novel statistical method to diagnose, quantify and correct batch effects in genomic studies. Sci. Rep. 7(1), 10849. https:\/\/doi.org\/10.1038\/s41598-017-11110-6 (2017).","journal-title":"Sci. Rep."},{"issue":"22\u201323","key":"9742_CR14","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1093\/bioinformatics\/btaa1018","volume":"36","author":"X Lu","year":"2021","unstructured":"Lu, X., Meng, J., Zhou, Y., Jiang, L. & Yan, F. MOVICS\u202f: An R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics 36(22\u201323), 5539\u20135541. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1018 (2021).","journal-title":"Bioinformatics"},{"issue":"1","key":"9742_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinf 14(1), 7. https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","journal-title":"BMC Bioinf"},{"issue":"7693","key":"9742_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan, S. et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693), 544\u2013548. https:\/\/doi.org\/10.1038\/nature25501 (2018).","journal-title":"Nature"},{"issue":"7","key":"9742_CR17","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.7150\/thno.53649","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu, J. et al. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Theranostics 11(7), 3089\u20133108. https:\/\/doi.org\/10.7150\/thno.53649 (2021).","journal-title":"Theranostics"},{"issue":"12","key":"9742_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.601","volume":"11","author":"X Lu","year":"2021","unstructured":"Lu, X. et al. Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies. Clin. Transl. Med. 11(12), e601. https:\/\/doi.org\/10.1002\/ctm2.601 (2021).","journal-title":"Clin. Transl. Med."},{"issue":"8","key":"9742_CR19","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1172\/JCI91095","volume":"127","author":"J Jeschke","year":"2017","unstructured":"Jeschke, J. et al. DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. J. Clin. Invest. 127(8), 3090\u20133102. https:\/\/doi.org\/10.1172\/JCI91095 (2017).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"9742_CR20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4(1), 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."},{"key":"9742_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume-title":"Cancer systems biology methods in molecular biology","author":"B Chen","year":"2018","unstructured":"Chen, B., Khodadoust, M. S., Liu, C. L., Newman, A. M. & Alizadeh, A. A. Profiling tumor infiltrating immune cells with CIBERSORT. In Cancer systems biology methods in molecular biology (ed. Von Stechow, L.) 243\u2013259 (Springer, New York, New York, 2018)."},{"key":"9742_CR22","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/j.csbj.2024.06.035","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection. Comput. Struct. Biotechnol. J. 23, 2798\u20132810. https:\/\/doi.org\/10.1016\/j.csbj.2024.06.035 (2024).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"11","key":"9742_CR23","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1158\/2159-8290.CD-15-0235","volume":"5","author":"B Seashore-Ludlow","year":"2015","unstructured":"Seashore-Ludlow, B. et al. Harnessing connectivity in a large-scale small-molecule sensitivity dataset. Cancer Discov. 5(11), 1210\u20131223. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0235 (2015).","journal-title":"Cancer Discov."},{"issue":"10031","key":"9742_CR24","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg, J. E. et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial. Lancet 387(10031), 1909\u20131920. https:\/\/doi.org\/10.1016\/S0140-6736(16)00561-4 (2016).","journal-title":"Lancet"},{"issue":"10122","key":"9742_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0140-6736(17)33297-X","volume":"391","author":"T Powles","year":"2018","unstructured":"Powles, T. et al. Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): A multicentre, open-label, phase 3 randomised controlled trial. Lancet 391(10122), 748\u2013757. https:\/\/doi.org\/10.1016\/S0140-6736(17)33297-X (2018).","journal-title":"Lancet"},{"issue":"23","key":"9742_CR26","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu, L. et al. TIP: A web server for resolving tumor immunophenotype profiling. Cancer Res. 78(23), 6575\u20136580. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0689 (2018).","journal-title":"Cancer Res."},{"issue":"10","key":"9742_CR27","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24(10), 1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1 (2018).","journal-title":"Nat. Med."},{"issue":"6625","key":"9742_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/386569a0","volume":"386","author":"M Ptashne","year":"1997","unstructured":"Ptashne, M. & Gann, A. Transcriptional activation by recruitment. Nature 386(6625), 569\u2013577. https:\/\/doi.org\/10.1038\/386569a0 (1997).","journal-title":"Nature"},{"issue":"5","key":"9742_CR29","doi-asserted-by":"publisher","first-page":"a019133","DOI":"10.1101\/cshperspect.a019133","volume":"6","author":"E Li","year":"2014","unstructured":"Li, E. & Zhang, Y. DNA methylation in mammals. Cold Spring Harb. Perspect. Biol. 6(5), a019133\u2013a019133. https:\/\/doi.org\/10.1101\/cshperspect.a019133 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"14","key":"9742_CR30","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.2174\/0929867328666211108105214","volume":"29","author":"S Zaib","year":"2022","unstructured":"Zaib, S., Rana, N. & Khan, I. Histone modifications and their role in epigenetics of cancer. Curr. Med. Chem. 29(14), 2399\u20132411. https:\/\/doi.org\/10.2174\/0929867328666211108105214 (2022).","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"9742_CR31","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.1038\/s41598-024-58434-8","volume":"14","author":"Z Du","year":"2024","unstructured":"Du, Z. et al. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas. Sci. Rep. 14(1), 9427. https:\/\/doi.org\/10.1038\/s41598-024-58434-8 (2024).","journal-title":"Sci. Rep."},{"key":"9742_CR32","doi-asserted-by":"publisher","first-page":"117793222412495","DOI":"10.1177\/11779322241249563","volume":"18","author":"FG Vieira","year":"2024","unstructured":"Vieira, F. G., Bispo, R. & Lopes, M. B. Integration of multi-omics data for the classification of glioma types and identification of novel biomarkers. Bioinforma. Biol. Insights 18, 11779322241249564. https:\/\/doi.org\/10.1177\/11779322241249563 (2024).","journal-title":"Bioinforma. Biol. Insights"},{"issue":"1","key":"9742_CR33","doi-asserted-by":"publisher","first-page":"bbac528","DOI":"10.1093\/bib\/bbac528","volume":"24","author":"H Yang","year":"2023","unstructured":"Yang, H. et al. From multi-omics data to the cancer druggable gene discovery: A novel machine learning-based approach. Brief. Bioinform. 24(1), bbac528. https:\/\/doi.org\/10.1093\/bib\/bbac528 (2023).","journal-title":"Brief. Bioinform."},{"issue":"141","key":"9742_CR34","doi-asserted-by":"publisher","first-page":"20170387","DOI":"10.1098\/rsif.2017.0387","volume":"15","author":"T Ching","year":"2018","unstructured":"Ching, T. et al. Opportunities and obstacles for deep learning in biology and medicine. J. R. Soc. Interface 15(141), 20170387. https:\/\/doi.org\/10.1098\/rsif.2017.0387 (2018).","journal-title":"J. R. Soc. Interface"},{"issue":"1","key":"9742_CR35","doi-asserted-by":"publisher","first-page":"bba461","DOI":"10.1093\/bib\/bbab461","volume":"23","author":"F Li","year":"2022","unstructured":"Li, F. et al. Positive-unlabeled learning in bioinformatics and computational biology: A brief review. Brief. Bioinform. 23(1), bba461. https:\/\/doi.org\/10.1093\/bib\/bbab461 (2022).","journal-title":"Brief. Bioinform."},{"issue":"7549","key":"9742_CR36","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/520609a","volume":"520","author":"NJ Schork","year":"2015","unstructured":"Schork, N. J. Personalized medicine: Time for one-person trials. Nature 520(7549), 609\u2013611. https:\/\/doi.org\/10.1038\/520609a (2015).","journal-title":"Nature"},{"key":"9742_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V. & Fotiadis, D. I. Machine learning applications in cancer prognosis and prediction. Comput. Struct. Biotechnol. J. 13, 8\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.005 (2015).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"9742_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12874-022-01768-6","volume":"22","author":"F Liu","year":"2022","unstructured":"Liu, F. & Panagiotakos, D. Real-world data: A brief review of the methods, applications, challenges and opportunities. BMC Med. Res. Methodol. 22(1), 287. https:\/\/doi.org\/10.1186\/s12874-022-01768-6 (2022).","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"9742_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen, D. S. & Mellman, I. Oncology meets immunology: The cancer-immunity cycle. Immunity 39(1), 1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012 (2013).","journal-title":"Immunity"},{"issue":"3","key":"9742_CR40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/ijms22031268","volume":"22","author":"P Balakrishna","year":"2021","unstructured":"Balakrishna, P., George, S., Hatoum, H. & Mukherjee, S. Serotonin pathway in cancer. Int. J. Mol. Sci. 22(3), 1268. https:\/\/doi.org\/10.3390\/ijms22031268 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"26","key":"9742_CR41","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian, S. L. et al. Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer. N. Engl. J. Med. 366(26), 2443\u20132454. https:\/\/doi.org\/10.1056\/NEJMoa1200690 (2012).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"9742_CR42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12(6), 492\u2013499. https:\/\/doi.org\/10.1038\/ni.2035 (2011).","journal-title":"Nat. Immunol."},{"issue":"1","key":"9742_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RGW Verhaak","year":"2010","unstructured":"Verhaak, R. G. W. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1), 98\u2013110. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.020 (2010).","journal-title":"Cancer Cell"},{"issue":"7","key":"9742_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.18632\/oncotarget.588","volume":"3","author":"Y Jiao","year":"2012","unstructured":"Jiao, Y. et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget 3(7), 709\u2013722. https:\/\/doi.org\/10.18632\/oncotarget.588 (2012).","journal-title":"Oncotarget"},{"issue":"1","key":"9742_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 32(1), 42-56.e6. https:\/\/doi.org\/10.1016\/j.ccell.2017.06.003 (2017).","journal-title":"Cancer Cell"},{"issue":"2","key":"9742_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/glioma.glioma_16_22","volume":"5","author":"X Wang","year":"2022","unstructured":"Wang, X., Wang, X. & Li, J. Overcoming T-Cell exhaustion in glioblastoma: A narrative review. Glioma 5(2), 56\u201361. https:\/\/doi.org\/10.4103\/glioma.glioma_16_22 (2022).","journal-title":"Glioma"},{"issue":"1","key":"9742_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41698-024-00717-4","volume":"8","author":"A Sarantopoulos","year":"2024","unstructured":"Sarantopoulos, A., Ene, C. & Aquilanti, E. Therapeutic approaches to modulate the immune microenvironment in gliomas. Npj Precis. Oncol. 8(1), 241. https:\/\/doi.org\/10.1038\/s41698-024-00717-4 (2024).","journal-title":"Npj Precis. Oncol."},{"issue":"29","key":"9742_CR48","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1200\/JCO.2013.48.6852","volume":"32","author":"KC Shih","year":"2014","unstructured":"Shih, K. C. et al. Successful treatment with dabrafenib (GSK2118436) in a patient with ganglioglioma. J. Clin. Oncol. 32(29), e98\u2013e100. https:\/\/doi.org\/10.1200\/JCO.2013.48.6852 (2014).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09742-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09742-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09742-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:22:52Z","timestamp":1757218972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09742-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9742"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09742-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24874"}}